Moreover, treatment of hepatoma cell lines with high doses of the iron chelator DFO (100 μM) upregulated Spns2, implying that iron deficiency might rescue the Spns1 phenotype by inducing Spns2 (50). This evidence concerns the gene SPNS1 and hepatocellular carcinoma.